PRESENTATION

Q4 2021 — Earnings presentation

Q4 2021PDF · 28 pages2.4 MB
Delivering a Smoke-Free Future
2021 Fourth-Quarter and
Full-Year Results
February 10, 2022
Introduction
• A glossary of key terms and definitions, including the definition for reduced-risk products, or
"RRPs," additional heated tobacco unit market data, as well as adjustments, other calculations and
reconciliations to the most directly comparable U.S. GAAP measures are at the end of today’s
webcast slides, which are posted on our website
• Unless otherwise stated, all references to IQOS are to our IQOS heat-not-burn products, and all
references to smoke-free products refer to RRPs
• Growth rates presented on an organic basis reflect currency-neutral underlying results
• Following the acquisitions of Fertin Pharma, OtiTopic, and Vectura Group, PMI added the "Other"
category in the third quarter of 2021. Business operations for the "Other" category are managed
and evaluated separately from the geographical operating segments
2

-- 1 of 28 --

Forward-Looking and Cautionary Statements
• This presentation and related discussion contains projections of future results and other forward-looking statements. Achievement of future results is subject to risks,
uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary
materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is
identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking
statements made by PMI
• PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness,
eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and
other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco use and intellectual property; intense competition; the
effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; changes in adult smoker behavior; lost revenues as
a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable currency exchange rates and currency devaluations, and
limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in the cost, availability, and quality of tobacco and other
agricultural products and raw materials, as well as components and materials for our electronic devices; and the integrity of its information systems and effectiveness of its
data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its attempts to produce and commercialize reduced-risk products
or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to successfully introduce new products, promote brand equity, enter
new markets or improve its margins through increased prices and productivity gains; if it is unable to expand its brand portfolio internally or through acquisitions and the
development of strategic business relationships; or if it is unable to attract and retain the best global talent. Future results are also subject to the lower predictability of our
reduced-risk product category's performance
• In addition, PMI’s business risks also include risks and uncertainties related to PMI’s acquisitions of Fertin Pharma A/S ("Fertin"), OtiTopic, Inc. ("OtiTopic") and Vectura
Group plc ("Vectura"), including, amongst other things: (1) the possibility that the integration of the operations of Fertin and Vectura with those of PMI may be more difficult
and/or take longer than anticipated, and may not accelerate PMI’s desired entry into additional smoke-free and beyond nicotine platforms as quickly as anticipated; (2) the
possibility that the respective integrations of Fertin and Vectura into PMI may be more costly than anticipated and may have unanticipated adverse results relating to
Fertin, Vectura or PMI’s existing businesses; (3) the inability to gain access to or acquire differentiated proprietary assets, technology and/or pharmaceutical development
expertise as anticipated by these acquisitions; (4) risks associated with third-party contracts containing consent and/or other contractual provisions that may be triggered
by the acquisitions; (5) the success of the research and development efforts of Fertin, OtiTopic and Vectura, including the ability to obtain regulatory approval for new
products, and the ability to commercialize or license these new products; (6) any unanticipated safety, quality or efficacy concerns and the impact of identified concerns
associated with the products developed by Fertin, OtiTopic and Vectura; and (7) the ability of PMI to retain key personnel of Fertin and Vectura, or hire key talent to work in
the Fertin and Vectura businesses due to their affiliation with PMI
• PMI is further subject to other risks detailed from time to time in its publicly filed documents, including the Form 10-Q for the quarter ended September 30, 2021 and PMI’s
Annual Report on Form 10-K for the fourth quarter and year ended December 31, 2021, which will be filed in the coming days. PMI cautions that the foregoing list of
important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking statement that we may make
from time to time, except in the normal course of its public disclosure obligations 	3
Forward-Looking and Cautionary Statements (COVID-19)
• The ongoing COVID-19 pandemic has created significant societal and economic disruption, and resulted in closures of stores,
factories and offices, and restrictions on manufacturing, distribution and travel, all of which may adversely impact our
business, results of operations, cash flows and financial position. Our business continuity plans and other safeguards may not
be effective to mitigate the impact of the pandemic
• Currently, significant risks include our diminished ability to convert adult smokers to our reduced-risk products, significant
volume declines in our duty-free business and certain other key markets, disruptions or delays in our manufacturing and
supply chain, increased currency volatility, and delays in certain cost saving, transformation and restructuring initiatives. Our
business could also be adversely impacted if key personnel or a significant number of employees or business partners become
unavailable due to the continuation of the COVID-19 pandemic. The significant adverse impact of COVID-19 on the
economic or political conditions in markets in which we operate could result in changes to the preferences of our adult
consumers and lower demand for our products, particularly for our mid-price or premium-price brands. Continuation of the
pandemic could disrupt our access to the credit markets or increase our borrowing costs. Governments may temporarily be
unable to focus on the development of science-based regulatory frameworks for the development and commercialization of
reduced-risk products or on the enforcement or implementation of regulations that are significant to our business. In
addition, messaging about the potential negative impacts of the use of our products in relation to COVID-19 risks may lead to
increasingly restrictive regulatory measures on the sale and use of our products, negatively impact demand for our products,
the willingness of adult consumers to switch to our reduced-risk products and our efforts to advocate for the development of
science-based regulatory frameworks for the development and commercialization of reduced-risk products
• The impact of these risks also depends on factors beyond our knowledge or control, including the duration and severity of the
pandemic, its recurrence in our key markets, actions taken to contain its spread and to mitigate its public health effects, and
the ultimate economic consequences thereof
4

-- 2 of 28 --

Strong 2021 Performance
5
• Excellent 2021 organic net revenue and EPS growth
• Reacceleration of performance in Q4
• Overall volume growth in Q4 and 2021
• Recovering IQOS user growth despite device supply
constraints:
⎼ 21.2m estimated IQOS users, +0.8m in Q4
⎼ 31% RRP organic net revenue growth in 2021
⎼ Smoke-free net revenues passing 30% of total PMI in Q4
• IQOS ILUMA superb start in Japan & Switzerland
• Improving market share in combustibles
• Milestone acquisitions to support long-term growth in
Wellness & Healthcare
• Returning strong cash flow to shareholders through
increased dividend and share repurchases
Source: PMI Financials or estimates
(a) Reflects total adjusted PMI net revenues divided by total PMI cigarette and HTU shipment volume
Source: PMI Financials or estimates 	6
FY, 2021: Excellent Net Revenue and EPS Growth
Adjusted Diluted EPS
(Currency neutral variance vs. PY) +15.3 %
OI Margin
(Organic variance vs. PY) +200 bps
Net Revenue per Unit(a)
(Organic variance vs. PY) +5.3 %
Adjusted Net Revenues
(Organic variance vs. PY) +7.6 %
Operating Cash Flow 	$12.0 bn

-- 3 of 28 --

(a) Reflects total adjusted PMI net revenues divided by total PMI cigarette and HTU shipment volume
Source: PMI Financials or estimates 	7
Q4, 2021: Strong Finish to the Year
Adjusted Diluted EPS
(Currency neutral variance vs. PY) +11.9 %
OI Margin
(Organic variance vs. PY) (10) bps
Net Revenue per Unit(a)
(Organic variance vs. PY) +4.1 %
Net Revenues
(Organic variance vs. PY) +8.4 %
(a) On an organic basis for revenues, margin expansion and on currency neutral basis for EPS
Source: PMI Financials or estimates
Strong 2022 Growth Fundamentals Driven by Innovation
• Strong growth outlook:
⎼ Improved IQOS device supply; exciting 2022 roster of
innovations and growth opportunities
⎼ Prudently factor in continuing uncertainty on device
supply and pandemic recovery
⎼ H2, 2021 user growth annualization
• 8-11% currency-neutral growth in adjusted
diluted EPS to forecast of $6.12-$6.30:
⎼ Includes unfavorable currency impact of ~45 cents at
prevailing exchange rates, notably due to the Euro,
Japanese Yen, Turkish Lira
⎼ Incorporates $785m share repurchases made
through December 31, 2021, and unfavorable impact
of acquisitions
8
FY22 Outlook(a)
HTU Shipment
Volume 113-118bn
Adj. Net Revenue
Growth 4-6%
Adjusted OI
Margin Expansion 50-150bps
Adjusted Diluted
EPS Growth 8-11%

-- 4 of 28 --

(a) Excluding China and the U.S. Includes Cigarettes and HTUs
Note: Operating cash flow is defined as net cash provided by operating activities
Source: PMI Financials or estimates
2022 Key Assumptions
9
2022
Forecast Assumptions
Total Industry Volume(a) -2 % to -1 %
PMI Total Shipment Volume 	-1 % to +1 %
Effective Tax Rate 	~22 %
Operating Cash Flow 	~$11.0 bn
Capital Expenditures 	~$1.0 bn
Q1’22 Adjusted Diluted EPS 	$1.50-$1.55
Source: PMI Financials or estimates 10
Strong HTU Performance Driving Total Volume Growth
Total PMI Shipment Volume (billion units)
154.7 	158.4
21.7 25.4
176.4 183.8
Q4, 2020 	Q4, 2021
HTUs
Cigarettes
Total
+17.0%
+2.4%
+4.2%
Change
vs. PY
628.5 	624.9
76.1 	95.0
704.6 	719.9
FY, 2020 	FY, 2021
HTUs
Cigarettes
Total
+24.8%
(0.6)%
+2.2%
Change
vs. PY
Full Year	Q4
+18.9
billion
(3.6)
billion

-- 5 of 28 --

HTU Volume Contribution Continues to Grow
(As a % of PMI Total Shipment Volume)
11
Note: Total volume includes HTUs and cigarettes
Source: PMI Financials or estimates
0.0% 0.9%
4.5% 5.3%
7.8%
10.8%
13.2%
2015 	2016 	2017 	2018 	2019 	2020 	2021
PMI HTU Shipment Volume (billion units)
7.4 	59.7	41.4	36.2	0.4 	76.1 	95.0
13.8%
Q4 2021
Note: Smoke-free net revenues include RRP net revenues and net revenues from the ‘Other’ category
Source: PMI Financials or estimates 	12
30% of Net Revenues Now Smoke-Free
(Smoke-Free Net Revenues as a % of Total PMI Adjusted Net Revenues)
0.2% 2.7%
12.7% 	13.8%
18.7%
23.8%
29.1%
2015 	2016 	2017 	2018 	2019 	2020 	2021 	2023 	2025
~40%
>50%
Ambition	Target
30.7%
Q4 2021

-- 6 of 28 --

13	Source: PMI Financials or estimates
Volume Growth & Twin Engines Powering Organic Net Revenues
+2.1pp
+2.7pp
FY, 2021
Shipment
Volume
Increase
Organic Net
Revenue
Growth
FY, 2021
Adjusted Net
Revenue
Growth
+10.3%
Category &
Market Mix
HTU and Device Pricing
Combustible Pricing
+7.6%
+0.3pp
Currency &
Acquisitions
+2.2%
+0.3pp
+3.0pp
14	Source: PMI Financials or estimates
Product Mix, Pricing & Efficiencies Driving OI Margin Expansion
+1.9pp
FY, 2020 	FY, 2021
(excluding currency & acquisition)
FY, 2021
SG&A & Other
Gross Margin
Expansion
+42.8%
Currency &
Acquisitions
+40.8%
+42.6%
Adjusted OI Margin
+0.1 	(0.2)pp

-- 7 of 28 --

Improved Combustible Share Trends
• Essentially stable year-over-year share of
combustibles in Q4, despite IQOS
cannibalization
• Continue to target stable cigarette share
over time to maximize switching to smoke-
free products
• Continued market recovery in Indonesia,
Mexico, Turkey
• Close-to-stable industry cigarette volumes
in EU Region, modest recovery in Duty-Free
15
Note: Excluding China and the U.S. Reflects sales volume of PMI cigarettes as a percentage of cigarette industry sales volume
Source: PMI Financials or estimates
(1.3)
(1.1)
(0.5)
(0.1)
2021 Share of Cigarette Market
(Change vs. PY in pp)
Share of
Cigarette
Market
24.2% 	24.9% 	25.5% 	25.0%
Q1 	Q2 	Q3 	Q4
Positive Total Market Share Momentum
16
(a) Reflects 68 markets where IQOS HTUs are available in key cities or nationwide at December 31, 2021. Excludes the U.S.
Note: Reflects sales volume as a percentage of the total industry sales volume for cigarettes and HTUs. Excluding China and the U.S. All ‘brands’ except ‘PMI HTUs’ include cigarettes only
Source: PMI Financials or estimates
2021 PMI Total International Share
(Change vs. PY in pp)
(0.9)
(0.7)
(0.1)
0.1	Q1 	Q2 	Q3
Q4
Share of Market (in %)
26.6 	27.3 	27.9 	27.4
3.5 	3.5 	3.6 	3.5
23.2 	23.8 	24.3 	23.8
Total
HTUs
Cigarettes
Q4’21 International Brand Share
in IQOS Markets(a)
13.1%
7.1%
4.3%
Marlboro 	Winston 	L&M 	Rothmans	PMI HTUs 	Camel
#3

-- 8 of 28 --

Total IQOS Users(a)
20.1
19.1
17.6
16.4
15.3
14.3
13.5
Estimated users who have switched to IQOS
and stopped smoking(a)
Estimated users who are in various stages of
conversion(a) 	20.4
Q2
2019
Q4 	Q1 	Q3
2020
Q4 	Q1 	Q2 	Q3 	Q4
2021
17
(a) See Glossary for definition
Source: PMI Financials or estimates, IQOS user panels and PMI Market Research
IQOS User Growth Recovering Despite Device Constraints
21.2
71% 	73% 	72% 	71% 	73% 	74% 	73% 	73% 	72%
EU Region: Strong Underlying HTU Growth
(a) Excluding the estimated impact of trade inventory movements
Note: Market share for HTUs is defined as the total sales volume for HTUs as a percentage of the total
estimated sales volume for cigarettes and HTUs
Source: PMI Financials or estimates
3.9% 	3.9% 	3.9%
5.0%
5.5% 5.3%
6.4%
Q1 	Q2 	Q3 	Q4 	Q1 	Q2 	Q3 	Q4
HTU SoM
2020 	2021
5.6%
18
Adj. IMS (a)
(in billion units)
4.1 4.5
5.2
5.7 6.0
6.7 7.0
7.5

-- 9 of 28 --

Accelerating Key City Shares in Europe
19
(a) Athens represents Attica Region
Source: PMI Financials or estimates
2.9% 	3.7% 	4.1% 5.9% 8.6% 	8.6% 	9.5%
14.7% 16.0% 16.5% 18.5% 21.6% 22.3% 
25.5%
37.5%
Madrid Stockholm Vienna 	London Bucharest Munich 	Zurich 	Warsaw 	Lisbon 	Milan 	Prague 	Rome 	Athens Budapest Vilnius
+0.8pp 	+2.1pp 	+2.6pp 	+2.0pp 	+3.2pp 	+4.8pp
PMI HTU Offtake Shares (Q4, 2021)
+0.9pp
Change vs. PY
+1.1pp 	+2.3pp 	+2.0pp 	+2.5pp 	+3.0pp	+2.8pp 	+5.2pp
(a)
+4.1pp
Eastern Europe: Robust Share Growth, Targeting Reacceleration
(a) Excluding the estimated impact of trade inventory movements
Note: Market share for HTUs is defined as the total sales volume for
HTUs as a percentage of the total estimated sales volume for
cigarettes and HTUs
Source: PMI Financials or estimates
Russia
Adj. IMS (a)
(in billion units)
EE Region
Adj. IMS (a)
(in billion units)
4.4 	4.7 5.2 5.8 	6.1 6.5 	6.3 	6.3
Russia HTU SoM	2.9 3.2 3.4
3.8 	3.9 	4.0 	4.0 	4.0
6.5%
6.0% 5.8%
7.2%
7.7%
7.3%
6.8%
8.0%
Q1 	Q2 	Q3 	Q4 	Q1 	Q2 	Q3 	Q4
2020 	2021 	20

-- 10 of 28 --

Q1 	Q2 	Q3 	Q4 	Q1 	Q2 	Q3 	Q4
6.7
7.1
7.6 	7.6 7.4
7.9 8.2 	8.1
Japan: Continued IQOS HTU and Category Growth
(a) Adjusted market share for HTUs is defined as the total sales volume for HTUs as a percentage of the total estimated sales
volume for cigarettes, HTUs and cigarillos and excluding the impact of estimated trade inventory movements
(b) Excluding the impact of estimated trade inventory movements
Source: PMI Financials or estimates
18.7% 	18.8%
20.1%
20.8% 	21.0%
17.8%
2020 	2021
Adjusted Total Tobacco SoM(a)	Adj. IMS (b)
(in billion units)
20.8%
21
21.8%
(a) Amman represents West Amman
Note: Exit shares represent estimated offtake share in December 2020 and December 2021
Source: PMI Financials or estimates
Promising IQOS Growth in Low & Middle-Income Markets
(PMI HTU offtake share in Key Cities)
22
Q4’20
Exit Share
Q4’21
Exit Share
Q4’20
Exit Share
Q4’21
Exit Share
Q4’20
Exit Share
Q4’21
Exit Share
Amman(a)
5.2%
8.4%
+3.2pp
Beirut 	12.5%
8.3% 	+4.2pp
3.6%	Urban Cairo
+3.6pp
+0.3pp
Guatemala City 	7.5%
7.2%
Kyiv 	28.0%
24.7% 	+3.3pp
Kuala Lumpur 	13.7%
12.5% 	+1.2pp
Metro Manila 	1.2%
0.8% 	+0.4p
+2.1pp
Santo Domingo
4.2%
6.3%
+2.5pp
Tbilisi 	8.9%
6.4%

-- 11 of 28 --

(a) Status at December 31, 2021
(b) Following recent international sanctions, IQOS is no longer available for sale in Belarus. IQOS is not currently available for sale in the U.S., following an importation ban and cease-and-
desist orders imposed by the International Trade Commission (effective November 29, 2021)
Note: Reflects markets where PMI smoke-free products are available in key cities or nationwide. Includes e-vapor launch in Finland and AG Snus products in Norway and Iceland. Reflects
date of initial geographic expansion beyond pilot launch city. The number of markets includes International Duty Free. Low & Middle-Income markets defined using World Bank
classification where available. Palestine is included as a Low & Middle-Income market
On Track to Reach 100 Markets by 2025
23
Market
Launches
2019 (8) (b)
2015 (7)
2016 (13)
2017 (18)
2018 (6)
2020 (12)
Current:
71
Markets
Worldwide(a)
Of which:
30
Low & Middle-
Income Markets
2021 (9)
Target:
100
Markets
by 2025
Superb Results of IQOS ILUMA in Japan
• Over 20% of ILUMA users are new
users, and over 20% of total IQOS users
now using ILUMA
• Encouraging boost to conversion rates
for upgraders:
⎼ Very positive feedback on reliability, no
need for cleaning
⎼ Higher retention and exclusive IQOS use
• TEREA the fastest-growing launch in the
smoke-free category with 8% offtake
share in 3 months
• Driving category growth post-October
price increase with premium product
24
(a) Based on 3 C-Store Chains offtake. Base includes cigarettes, cigarillos and RRP. Data to January 2, 2022
Note: New users are former Legal Age Smokers or Legal Age Nicotine Users
Source: PMI Financials or estimates
Japan Offtake Share (a)
0%
5%
10%
15%
20%
Marlboro
Heatsticks
(9.8%)
TEREA
(8.0%)
HEETS
(5.0%)
Dec	Aug 	Oct 	Nov	Sep	Jul
Total PMI
HTU
(22.8%)

-- 12 of 28 --

Remarkable Start for IQOS ILUMA in Switzerland
• Switzerland exhibiting similar or better
early trends since early November
launch
• Accelerated smoker acquisition and
upgrades from existing users
• TEREA around 1/3 of PMI HTU sales
since launch
25	Note: Chart represents share of market in the months of March, June, September and December
Source: PMI Financials or estimates
2021 Switzerland HTU SoM
5.7% 5.5%
6.0%
7.9%
Mar 	June 	Sep 	Dec
3%
Exciting Launch Plans for ILUMA and Other HnB Innovations
• Strong potential confirmed in Japan and
Switzerland
• Plan to gradually roll out to more markets this
year, mostly in H2
• Co-existence with blade products broadens
portfolio & enables segmentation
• Rich pipeline of innovations on devices and
consumables across HnB technologies:
⎼ IQOS ILUMA (3 devices)
⎼ IQOS 3 DUO
⎼ LIL
⎼ New complementary technology for low & middle-
income markets
• HTU portfolio expansion
26

-- 13 of 28 --

IQOS VEEV: Very Promising Results
• Strong progress following distribution and
consumable range expansions
• Premium product resonating with
consumers
• Further market roll-outs planned this year
• Now assume U.S. FDA PMTA filing in early
2023
27
(a) Source: Nielsen, Indirect retail only (~60%)
(b) Source: Key Account sales
Note: IMS share data based on ml
Source: PMI Financials or estimates
0%
5%
10%
15%
20%
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2021 VEEV IMS Share
(Closed System Pods)
Croatia(b)
Czech
Republic(b)
Italy (a)
Nicotine Pouches to Support Smoke-Free Growth Engine
• Intention to become a leading player in the nicotine
pouch category with Shiro
• Convenient and appealing smoke-free alternative
for adult smokers with portfolio of flavors,
strengths
• Product development and manufacturing base
established; smoke-free commercial infrastructure
allows fast roll-out
• Multiple market launches planned over coming
quarters
• Full re-launch of Shiro portfolio in Nordics in
February 2022
28

-- 14 of 28 --

Investing in Wellness & Healthcare for Long-Term Growth
• Building critical development platform with
Fertin & Vectura acquisitions:
⎼ Strong oral and respiratory delivery capabilities
⎼ Complements PMI respiratory expertise
• Underlying performance of acquired business as
expected:
⎼ Nicotine products (Fertin) made up 39% of Q4 net
revenues
• Ongoing investment in 2022 to impact bottom
line
• Aiming for meaningful revenue growth from new
areas in 2-3 years driven by investment
29
Note: CDMO stands for Contract Development & Manufacturing Organizations. NRT represents smoking cessation products and NCP represents nicotine pouches
Source: PMI Financials or estimates
39%	61%
Total
$101
million
NRT / NCP
Q4’21 "Other" Category Revenues
Other Product
Supply, Royalties
& Others
Enhancing approach to sustainability:
• New sustainability materiality assessment completed, results to be
published next week in a dedicated report
• Strengthening link with executive compensation through new
Sustainability Index based on materiality
• Included in Dow Jones Sustainability Index (DJSI) North America for
second year and included in its sustainability yearbook, silver class
Environmental impact:
• CDP ‘Triple A’ certification for climate change, forests and water
security & CDP supplier engagement leader
Social impact:
• Publication of Agricultural Labor Practices (ALP) report to mark 10
years of leading ALP program
• Inclusion in Bloomberg Gender-Equality Index for second year
Product impact:
• Growing penetration of smoke-free products to accelerate the end of
smoking
• Continued positive regulatory developments recognizing harm
reduction credentials of smoke-free products
Transforming for a Sustainable Future
30

-- 15 of 28 --

31
Strong 2021 Delivered, Strong 2022 Expected
• 	Record adjusted EPS, net revenues and cash-
flow; excellent growth
• 	Strong underlying momentum for IQOS
• 	Broadening smoke-free portfolio & geographic
reach
• 	Investing for long-term growth in Wellness &
Healthcare
• 	Increasing cash returns to shareholders
• 	More exciting innovations in 2022; IQOS user
growth to re-accelerate as device shortages
ease
• 	On track for 2021-23 growth algorithm and
2025 smoke-free net revenue ambition
Source: PMI Financials or estimates
Delivering a Smoke-Free Future
2021 Fourth-Quarter and
Full-Year Results
Questions & Answers
iOS Download 	Android Download	Have you downloaded the PMI Investor Relations App?
The free IR App is available to download at the Apple App Store
for iOS devices and at Google Play for Android mobile devices
Or go to: www.pmi.com/irapp

-- 16 of 28 --

Delivering a Smoke-Free Future
2021 Fourth-Quarter and
Full-Year Results
February 10, 2022
34
Glossary of Key Terms and Definitions,
Appendix, and
Reconciliation of Non-GAAP Measures

-- 17 of 28 --

Glossary: General Terms
• "PMI" refers to Philip Morris International Inc. and its subsidiaries. Trademarks and service marks that are the registered property of, or
licensed by, the subsidiaries of PMI, are italicized
• Until March 28, 2008, PMI was a wholly owned subsidiary of Altria Group, Inc. ("Altria"). Since that time the company has been independent and
is listed on the New York Stock Exchange (ticker symbol "PM")
• Comparisons are made to the same prior-year period unless otherwise stated
• Unless otherwise stated, references to total industry, total market, PMI shipment volume and PMI market share performance reflect cigarettes
and heated tobacco units
• References to total international market, defined as worldwide cigarette and heated tobacco unit volume excluding the U.S., total industry, total
market and market shares are PMI estimates for tax-paid products based on the latest available data from a number of internal and external
sources and may, in defined instances, exclude the People's Republic of China and/or PMI's duty free business
• 2020 and 2021 estimates for total industry volume and market share in certain geographies reflect limitations on the availability and accuracy
of industry data during pandemic-related restrictions
• "OTP" is defined as "other tobacco products," primarily roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos, and
does not include reduced-risk products
• "Combustible products" is the term PMI uses to refer to cigarettes and OTP, combined
• In-market sales, or "IMS," is defined as sales to the retail channel, depending on the market and distribution model
• "Total shipment volume" is defined as the combined total of cigarette shipment volume and heated tobacco unit shipment volume
• Following the acquisitions of Fertin Pharma A/S, OtiTopic, Inc. and Vectura Group plc., PMI added the "Other" category in the third quarter of
2021. Business operations for the Other category are evaluated separately from the geographical operating segments
• "RBH" refers to PMI’s Canadian subsidiary, Rothmans, Benson & Hedges Inc.
• The Companies’ Creditors Arrangement Act (CCAA) is a Canadian federal law that permits a Canadian business to restructure its affairs while
carrying on its business in the ordinary course
35
Glossary: General Terms (cont.)
• "EU" is defined as the European Union Region
• "EE" is defined as the Eastern Europe Region
• "ME&A" is defined as the Middle East & Africa Region and includes PMI's duty free business
• "S&SA" is defined as the South & Southeast Asia Region
• "EA&A" is defined as the East Asia & Australia Region
• “AMCS” is defined as the Americas Region. It refers to the former Latin America & Canada segment, which was renamed as the Americas
segment as of the third quarter of 2021. References to "Americas" may, in defined instances, exclude the U.S.
• Following the deconsolidation of PMI's Canadian subsidiary, Rothmans, Benson & Hedges, Inc. (RBH), PMI will continue to report the volume of
brands sold by RBH for which other PMI subsidiaries are the trademark owner. These include HEETS, Next, Philip Morris and Rooftop
• From time to time, PMI’s shipment volumes are subject to the impact of distributor inventory movements, and estimated total industry/market
volumes are subject to the impact of inventory movements in various trade channels that include estimated trade inventory movements of
PMI’s competitors arising from market-specific factors that significantly distort reported volume disclosures. Such factors may include changes
to the manufacturing supply chain, shipment methods, consumer demand, timing of excise tax increases or other influences that may affect the
timing of sales to customers. In such instances, in addition to reviewing PMI shipment volumes and certain estimated total industry/market
volumes on a reported basis, management reviews these measures on an adjusted basis that excludes the impact of distributor and/or estimated
trade inventory movements. Management also believes that disclosing PMI shipment volumes and estimated total industry/market volumes in
such circumstances on a basis that excludes the impact of distributor and/or estimated trade inventory movements, such as on an IMS basis,
improves the comparability of performance and trends for these measures over different reporting periods
• "ESG" stands for environmental, social, and governance
• "Illicit trade" refers to domestic non-tax paid products
• "SoM" stands for share of market
36

-- 18 of 28 --

Glossary: Financial Terms
• Net revenues related to combustible products refer to the operating revenues generated from the sale of these products, including shipping
and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. PMI recognizes revenue when control is
transferred to the customer, typically either upon shipment or delivery of goods
• Net revenues related to RRPs represent the sale of heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-
containing products, primarily e-vapor and oral nicotine products, including shipping and handling charges billed to customers, net of sales
and promotion incentives, and excise taxes. PMI recognizes revenue when control is transferred to the customer, typically either upon
shipment or delivery of goods
• Net revenues in the Other category primarily consist of operating revenues generated from the sale of inhaled therapeutics, and oral and
intra-oral delivery systems, resulting from the third quarter 2021 acquisitions of Fertin Pharma A/S, OtiTopic, Inc. And Vectura Group plc.
• Adjusted net revenues exclude the impact related to the Saudi Arabia customs assessments
• "SG&A" stands for selling, general & administrative
• "Adjusted Operating Income (OI) Margin" is calculated as adjusted OI, divided by adjusted net revenues
• "Net debt" is defined as total debt, less cash and cash equivalents
• Growth rates presented on an organic basis for consolidated financial results reflect currency-neutral underlying results
• Management reviews net revenues, operating income, operating income margin, operating cash flow and earnings per share, or "EPS," on an
adjusted basis, which may exclude the impact of currency and other items such as acquisitions, asset impairment and exit costs, tax items and
other special items. Currency-neutral and organic growth rates reflect the way management views underlying performance for these
measures. PMI believes that such measures provide useful insight into underlying business trends and results. Management reviews these
measures because they exclude changes in currency exchange rates and other factors that may distort underlying business trends, thereby
improving the comparability of PMI’s business performance between reporting periods. Furthermore, PMI uses several of these measures in
its management compensation program to promote internal fairness and a disciplined assessment of performance against company targets.
PMI discloses these measures to enable investors to view the business through the eyes of management
• "Fair value adjustment for equity security investments" reflects the adjustment resulting from share price movements in passive
investments for publicly traded entities that are not controlled or influenced by PMI. Under U.S. GAAP, such adjustments are required, since
January 1, 2018, to be reflected directly in the income statement
37
Glossary: Reduced-Risk Products
• Reduced-risk products (“RRPs”) is the term PMI uses to refer to products that present, are likely to present, or have the potential to
present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of
development, scientific assessment and commercialization. PMI's RRPs are smoke-free products that contain and/or generate far lower
quantities of harmful and potentially harmful constituents than found in cigarette smoke
• "Aerosol" refers to a gaseous suspension of fine solid particles and/or liquid droplets
• "Combustion" is the process of burning a substance in oxygen, producing heat and often light
• "Smoke" is a visible suspension of solid particles, liquid droplets and gases in air, emitted when a material burns
• "Heated tobacco units," or "HTUs," is the term PMI uses to refer to heated tobacco consumables, which for PMI include the company's
HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro and HEETS FROM MARLBORO (defined collectively as HEETS), Marlboro
Dimensions, Marlboro HeatSticks, Parliament HeatSticks and Terea, as well as the KT&G-licensed brand, Fiit and Miix (outside of South Korea)
• IQOS heat-not-burn devices are precisely controlled heating devices into which a specially designed and proprietary tobacco units are
inserted and heated to generate an aerosol
• "PMI heat-not-burn products" include licensed KT&G heat-not-burn products
• "PMI HTUs" include licensed KT&G HTUs
• HTU "offtake volume" represents the estimated retail offtake of HTUs based on a selection of sales channels that vary by market, but
notably include retail points of sale and e-commerce platforms
• HTU "offtake share" represents the estimated retail offtake volume of HTUs divided by the sum of estimated total offtake volume for
cigarettes and HTUs
• Market share for HTUs is defined as the total sales volume for HTUs as a percentage of the total estimated sales volume for cigarettes and
HTUs
38

-- 19 of 28 --

Glossary: Reduced-Risk Products (cont.)
• "Total IQOS users" is defined as the estimated number of Legal Age (minimum 18 years) users of PMI heat-not-burn products for which PMI
HTUs represented at least 5% of their daily tobacco consumption over the past seven days
The estimated number of adults who have "switched to IQOS and stopped smoking" reflects:
⎼ for markets where there are no heat-not-burn products other than PMI heat-not-burn products: daily individual consumption of PMI HTUs represents
the totality of their daily tobacco consumption in the past seven days
⎼ for markets where PMI heat-not-burn products are among other heat-not-burn products: daily individual consumption of HTUs represents the totality
of their daily tobacco consumption in the past seven days, of which at least 70% is PMI HTUs.
Note: The above IQOS user metrics reflect PMI estimates based on consumer claims and sample-based statistical assessments, the accuracy
and reliability of which may vary based on individual market maturity and availability of information. The average margin of error for IQOS
users in key volume markets is +/-5% at a 95% Confidence Interval
As of December 2020, PMI heat-not-burn products and HTUs include licensed KT&G heat-not-burn products and HTUs, respectively
• "FDA" stands for the U.S. Food & Drug Administration
• "MRTP" stands for Modified Risk Tobacco Product, the term used by the U.S. FDA to refer to RRPs
• "MRTP application" stands for Modified Risk Tobacco Product application under section 911 of the FD&C Act
• "PMTA" stands for Premarket Tobacco Application under section 910 of the FD&C Act
• "Acquisition" refers to our efforts to switch LAS from smoking cigarettes to RRPs or to switch LAU from competing smoke-free products to
PMI’s RRPs
• "Retention" refers to our efforts to deter LAU from going back to smoking cigarettes or from choosing a competing smoke-free product instead
of a PMI RRP
39
Glossary: IQOS in the United States
• On April 30, 2019, the U.S. Food and Drug Administration (FDA) announced that the marketing of a version of PMI's Platform 1 product, namely, IQOS
2.4, together with its heated tobacco units (the term PMI uses to refer to heated tobacco consumables), is appropriate for the protection of public health
and authorized it for sale in the U.S. The FDA’s decision followed its comprehensive assessment of PMI’s premarket tobacco product applications
(PMTAs) submitted to the Agency in 2017
• In the third quarter of 2019, PMI brought IQOS 2.4 and three variants of its heated tobacco units to the U.S. through its license with Altria Group, Inc.,
whose subsidiary, Philip Morris USA Inc., is responsible for marketing the product and complying with the provisions set forth in the FDA's marketing
orders
• On July 7, 2020, the FDA authorized the marketing of a version of PMI's Platform 1 product, namely, IQOS 2.4, together with its heated tobacco units, as a
Modified Risk Tobacco Product (MRTP). In doing so, the agency found that an IQOS exposure modification order is appropriate to promote the public
health. The decision followed a review of the extensive scientific evidence package PMI submitted to the FDA in December 2016 to support its MRTP
applications
• On December 7, 2020, the FDA confirmed that the marketing of a version of PMI's Platform 1 product, namely, IQOS 3, is appropriate for the protection
of public health and authorized it for sale in the U.S. The FDA’s decision followed an assessment of a PMI's PMTA filed with the agency in March 2020
• On November 29, 2021, an importation ban and cease-and-desist orders imposed by the U.S. International Trade Commission (ITC) relating to IQOS
Platform 1 products (including consumables and infringing components) went into effect. As a result, IQOS is not currently available for sale in the U.S.
PMI has appealed the patent and statutory issues related to the ITC's Final Determination, and also has contingency plans underway, including domestic
production. PMI believes it is unlikely that IQOS will be available in the U.S. in 2022. For more details on the ITC case and related legal matters, please
refer to PMI's Form 10-K for 2021, which the company plans to file with the SEC in the coming days. Note: The ITC decision has no bearing outside the
U.S.; competitor lawsuits based on the same patent families have repeatedly and universally failed in European courts and the European Patent Office
• Shipment volume of heated tobacco units to the U.S. is included in the heated tobacco unit shipment volume of the Americas segment. Revenues from
shipments of Platform 1 devices, heated tobacco units and accessories to Altria Group, Inc. for sale under license in the U.S. are included in Net Revenues
of the Americas
40

-- 20 of 28 --

41
2015 	2016 	2017 	2018 	2019 	2020 	2021
R&D expenditure
(smoke-free/total) 	70% 	72% 	74% 	92% 	98% 	99% 	99%
Commercial expenditure (Marketing)
(smoke-free/total) 	8% 	15% 	39% 	60% 	71% 	76% 	73%
Net revenues
(smoke-free/total) 	0.2% 	2.7% 	12.7% 	13.8% 	18.7% 	23.8% 	29.1%
Smoke-free product shipment ratio(a)
(smoke-free/total) 	0.1% 	0.9% 	4.4% 	5.1% 	7.6% 	10.4% 	12.8%
Estimated users who have stopped smoking
and switched to IQOS(b) (in millions) 	- 	1.5 	4.7 	6.6 	9.6 	12.8 	15.3
Number of markets where net revenues
from smoke-free products exceed 50% of
total net revenues
- 	- 	1 	3 	4 	5 	10
(a) The smoke-free product shipment ratio is computed based on millions of units. Smoke-free products include heated tobacco units, e-cigarettes, snus and nicotine pouches. Total products
include smoke-free products, cigarettes and other combustible products
(b) See Glossary for definition
Source: PMI Financials or estimates, IQOS user panels and PMI Market Research
Business Transformation Metrics
Shifting Our Resources to Deliver a Smoke-Free Future
EU Region: HTU SoM Performance in Select Markets
Note: Select markets where HTU share is ≥ 1%. Sales volume of PMI HTUs as a percentage of the total industry sales volume for cigarettes and HTUs
Source: PMI Financials or estimates 	42
Q4, 2021
Growth
vs. PY 	Q4, 2021
Growth
vs. PY 	Q4, 2021
Growth
vs. PY
Croatia 	6.5% 	+0.7pp 	Italy 	12.7% 	+3.1pp 	Romania 	4.6% 	+1.3pp
Czech
Republic 	11.8 	+1.6 	Latvia 	11.8 	(2.9) Slovak
Republic 	14.0 	+3.8
Germany 	3.5 	+0.9 	Lithuania 	25.9 	+3.1 	Slovenia 	9.1 	+2.8
Greece 	15.8 	+2.7 	Poland 	7.4 	‒ 	Switzerland 	7.4 	+2.6
Hungary 	20.1 	+6.8 	Portugal 	13.7 	+2.8 	UK 	2.7 	+0.9

-- 21 of 28 --

Source: PMI Financials or estimates
2022
Forecast 	2021 	Growth
Reported Diluted EPS 	$6.12 – $6.30 	$5.83
- Saudi Arabia customs assessments 	– 	0.14
- Asset impairment and exit costs 	– 	0.12
- Asset acquisition cost 	– 	0.03
- Equity investee ownership dilution 	– 	(0.04)
Adjusted Diluted EPS 	$6.12 – $6.30 	$6.08
- Currency 	(0.45)
Adjusted Diluted EPS, excluding currency 	$6.57 – $6.75 	$6.08 	8% – 11%
2022: EPS Guidance
($/share)
43
Full-Year
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
44
Reconciliation of Reported Diluted EPS to Reported Diluted EPS, excluding Currency,
and Reconciliation of Reported Diluted EPS to Adjusted Diluted EPS, excluding Currency
(Unaudited)
Quarters Ended December 31,
2021 	2020 	% Change
Reported Diluted EPS 	$ 1.34 	$ 1.27 	5.5%
Less: Currency 	(0.06)
Reported Diluted EPS, excluding Currency 	$ 1.40 	$ 1.27 	10.2%
Quarters Ended December 31, 	Year Ended
2021 	2020 	% Change 	2020
Reported Diluted EPS 	$ 1.34 	$ 1.27 	5.5% 	$ 5.16
Asset impairment and exit costs 	0.02 	0.04 	0.08
Equity investee ownership dilution 	(0.01) 	- 	-
Fair value adjustment for equity security investments 	- 	- 	0.04
Tax items 	- 	- 	(0.06)
Brazil indirect tax credit 	- 	(0.05) 	(0.05)
Adjusted Diluted EPS 	$ 1.35 	$ 1.26 	7.1% 	$ 5.17
Less: Currency 	(0.06)
Adjusted Diluted EPS, excluding Currency 	$ 1.41 	$ 1.26 	11.9%

-- 22 of 28 --

45
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Net Revenues by Product Category and Adjustments of Net Revenues for the Impact of Currency and Acquisitions
($ in millions) / (Unaudited)
Note: Sum of product categories or Regions might not foot to Total PMI due to roundings. “-“ indicates amounts between -$0.5 million and +$0.5 million
Currency
Net
Revenues
excluding
Currency
Acquisitions
Net
Revenues
excluding
Currency &
Acquisitions
Quarters Ended
December 31,
Net
Revenues 	Total 	Excluding
Currency
Excluding
Currency &
Acquisitions
2021 	Reduced-Risk Products 	2020 	% Change
$ 1,097 	$ (13) 	$ 1,110 	$ 6 	$ 1,104 	European Union 	$ 789 	39.1% 	40.7% 	40.0%
353 	$ 17 	336 	- 	336 	Eastern Europe 	339 	4.2% 	(0.8)% 	(0.8)%
47 	$ - 	47 	- 	47 	Middle East & Africa 	5 	+100% 	+100% 	+100%
4 	$ - 	4 	- 	4 	South & Southeast Asia 	1 	+100% 	+100% 	+100%
880 	$ (30) 	910 	- 	910 	East Asia & Australia 	792 	11.0% 	14.8% 	14.8%
10 	$ - 	10 	- 	10 	Americas 	11 	(5.4)% 	(7.3)% 	(7.3)%
$ 2,391 	$ (25) 	$ 2,416 	$ 6 	$ 2,410 	Total RRPs 	$ 1,937 	23.4% 	24.7% 	24.4%
2021 	Other 	2020 	% Change
$ 101 	$ - 	$ 101 	$ 101 	$ - 	Other 	$ - 	- 	- 	-
2021 	PMI 	2020 	% Change
$ 3,025 	$ (33) 	$ 3,058 	$ 6 	$ 3,052 	European Union 	$ 2,742 	10.3% 	11.5% 	11.3%
912 	42 	870 	- 	870 	Eastern Europe 	908 	0.4% 	(4.2)% 	(4.2)%
987 	(49) 	1,036 	- 	1,036 	Middle East & Africa 	740 	33.4% 	40.0% 	40.0%
1,112 	(3) 	1,115 	- 	1,115 	South & Southeast Asia 	1,185 	(6.2)% 	(5.9)% 	(5.9)%
1,444 	(39) 	1,483 	- 	1,483 	East Asia & Australia 	1,384 	4.3% 	7.2% 	7.2%
523 	8 	515 	- 	515 	Americas 	485 	7.8% 	6.2% 	6.2%
101 	- 	101 	101 	- 	Other 	- 	- 	- 	-
$ 8,104 	$ (74) 	$ 8,178 	$ 107 	$ 8,071 	Total PMI 	$ 7,444 	8.9% 	9.9% 	8.4%
Net
Revenues
46
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Net Revenues to Adjusted Net Revenues, excluding Currency and Acquisitions
($ in millions) / (Unaudited)
Net
Revenues
Adjusted
Net
Revenues
Currency
Adjusted
Net
Revenues
excluding
Currency
Acqui-
sitions
Adjusted
Net
Revenues
excluding
Currency
& Acqui-
sitions
Net
Revenues
Adjusted
Net
Revenues
Total 	Excluding
Currency
Excluding
Currency
& Acqui-
sitions
2021 	2020
$ 3,025 	$ - 	$ 3,025 	$ (33) 	$ 3,058 	$ 6 	$ 3,052 	European Union 	$ 2,742 	$ - 	$ 2,742 	10.3% 	11.5% 	11.3%
912 	- 	912 	42 	870 	- 	870 	Eastern Europe 	908 	- 	908 	0.4% 	(4.2)% 	(4.2)%
987 	- 	987 	(49) 	1,036 	- 	1,036 	Middle East & Africa 	740 	- 	740 	33.4% 	40.0% 	40.0%
1,112 	- 	1,112 	(3) 	1,115 	- 	1,115 	South & Southeast Asia 	1,185 	- 	1,185 	(6.2)% 	(5.9)% 	(5.9)%
1,444 	- 	1,444 	(39) 	1,483 	- 	1,483 	East Asia & Australia 	1,384 	- 	1,384 	4.3% 	7.2% 	7.2%
523 	- 	523 	8 	515 	- 	515 	Americas 	485 	- 	485 	7.8% 	6.2% 	6.2%
101 	- 	101 	- 	101 	101 	- 	Other 	- 	- 	- 	- 	- 	-
$ 8,104 	$ - 	$ 8,104 	$ (74) 	$ 8,178 	$ 107 	$ 8,071 	Total PMI 	$ 7,444 	$ - 	$ 7,444 	8.9% 	9.9% 	8.4%
Special
Items
Special
Items
Quarters Ended
December 31, 	% Change

-- 23 of 28 --

47
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Operating Income to Adjusted Operating Income, excluding Currency and Acquisitions
($ in millions) / (Unaudited)
(a) Represents asset impairment and exit costs
(b) Includes the Brazil indirect tax credit $119 million and asset impairment and exit costs ($5 million)
Operating
Income
Adjusted
Operating
Income
Currency
Adjusted
Operating
Income
excluding
Currency
Acqui-
sitions
Adjusted
Operating
Income
excluding
Currency
& Acqui-
sitions
Operating
Income
Adjusted
Operating
Income
Total 	Excluding
Currency
Excluding
Currency
& Acqui-
sitions
2021 	2020
$ 1,308 	$ (12) (a)	
$ 1,320 	$ (29) 	$ 1,349 	$ 2 	$ 1,347 	European Union 	$ 1,174 	$ (30) (a)	
$ 1,204 	9.6% 	12.0% 	11.9%
300 	(3) (a)	
303 	9 	294 	- 	294 	Eastern Europe 	261 	(8) (a)	
269 	12.6% 	9.3% 	9.3%
407 	(4) (a)	
411 	(50) 	461 	- 	461 	Middle East & Africa 	207 	(10) (a)	
217 	89.4% 	+100% 	+100%
298 	(4) (a)	
302 	- 	302 	- 	302 	South & Southeast Asia 	419 	(12) (a)	
431 	(29.9)% 	(29.9)% 	(29.9)%
515 	(21) (a)	
536 	(47) 	583 	- 	583 	East Asia & Australia 	608 	(13) (a)	
621 	(13.7)% 	(6.1)% 	(6.1)%
120 	(2) (a)	
122 	6 	116 	- 	116 	Americas 	236 	114 (b)	
122 	- 	(4.9)% 	(4.9)%
(1) 	- 	(1) 	- 	(1) 	(1) 	- 	Other 	- 	- 	- 	- 	- 	-
$ 2,947 	$ (46) 	$ 2,993 	$ (111) 	$ 3,104 	$ 1 	$ 3,103 	Total PMI 	$ 2,905 	$ 41 	$ 2,864 	4.5% 	8.4% 	8.3%
Asset
Impairment
& Exit Costs
and Others
% Change
	Quarters Ended
December 31,
Asset
Impairment
& Exit Costs
48
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Adjusted Operating Income Margin, excluding Currency and Acquisitions
($ in millions) / (Unaudited)
(a) For the calculation of Adjusted Operating Income and Adjusted Operating Income excluding currency and acquisitions refer to slide 47
(b) For the calculation of Adjusted Net Revenues and Adjusted Net Revenues excluding currency and acquisitions refer to slide 46
Adjusted
Operating
Income
(a)
Adjusted
Net
Revenues
(b)
Adjusted
Operating
Income
Margin
Adjusted
Operating
Income
excluding
Currency
(a)
Adjusted
Net
Revenues
excluding
Currency
(b)
Adjusted
Operating
Income
Margin
excluding
Currency
Adjusted
Operating
Income
excluding
Currency &
Acqui-
sitions (a)
Adjusted
Net
Revenues
excluding
Currency &
Acqui-
sitions (b)
Adjusted
Operating
Income
Margin
excluding
Currency &
Acqui-
sitions
Adjusted
Operating
Income
(a)
Adjusted
Net
Revenues
(b)
Adjusted
Operating
Income
Margin
Adjusted
Operating
Income
Margin
Adjusted
Operating
Income
Margin
excluding
Currency
Adjusted
Operating
Income
Margin
excluding
Currency &
Acqui-
sitions
2021 	2020 	% Points Change
$ 1,320 	$ 3,025 	43.6% 	$ 1,349 	$ 3,058 	44.1% 	$ 1,347 	$ 3,052 	44.1% 	European Union 	$ 1,204 	$ 2,742 	43.9% 	(0.3) 	0.2 	0.2
303 	912 	33.2% 	294 	870 	33.8% 	294 	870 	33.8% 	Eastern Europe 	269 	908 	29.6% 	3.6 	4.2 	4.2
411 	987 	41.6% 	461 	1,036 	44.5% 	461 	1,036 	44.5% 	Middle East & Africa 	217 	740 	29.3% 	12.3 	15.2 	15.2
302 	1,112 	27.2% 	302 	1,115 	27.1% 	302 	1,115 	27.1% South & Southeast Asia 	431 	1,185 	36.4% 	(9.2) 	(9.3) 	(9.3)
536 	1,444 	37.1% 	583 	1,483 	39.3% 	583 	1,483 	39.3% 	East Asia & Australia 	621 	1,384 	44.9% 	(7.8) 	(5.6) 	(5.6)
122 	523 	23.3% 	116 	515 	22.5% 	116 	515 	22.5% 	Americas 	122 	485 	25.2% 	(1.9) 	(2.7) 	(2.7)
(1) 	101 	(1.0)% 	(1) 	101 	(1.0)% 	- 	- 	- 	Other 	- 	- 	- 	- 	- 	-
$ 2,993 	$ 8,104 	36.9% 	$ 3,104 	$ 8,178 	38.0% 	$ 3,103 	$ 8,071 	38.4% 	Total PMI 	$ 2,864 	$ 7,444 	38.5% 	(1.6) 	(0.5) 	(0.1)
Quarters Ended
December 31,

-- 24 of 28 --

PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
49
Reconciliation of Reported Diluted EPS to Reported Diluted EPS, excluding Currency,
and Reconciliation of Reported Diluted EPS to Adjusted Diluted EPS, excluding Currency
(Unaudited)
Years Ended December 31,
2021 	2020 	% Change
Reported Diluted EPS 	$ 5.83 	$ 5.16 	13.0%
Less: Currency 	0.12
Reported Diluted EPS, excluding Currency 	$ 5.71 	$ 5.16 	10.7%
Years Ended December 31,
2021 	2020 	% Change
Reported Diluted EPS 	$ 5.83 	$ 5.16 	13.0%
Saudi Arabia customs assessments 	0.14 	-
Asset impairment and exit costs 	0.12 	0.08
Asset acquisition cost 	0.03 	-
Equity investee ownership dilution 	(0.04) 	-
Fair value adjustment for equity security investments 	- 	0.04
Tax items 	- 	(0.06)
Brazil indirect tax credit 	- 	(0.05)
Adjusted Diluted EPS 	$ 6.08 	$ 5.17 	17.6%
Less: Currency 	0.12
Adjusted Diluted EPS, excluding Currency 	$ 5.96 	$ 5.17 	15.3%
50
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Net Revenues by Product Category and Adjustments of Net Revenues for the Impact of Currency and Acquisitions
($ in millions) / (Unaudited)
(a) Includes a reduction in net revenues of $246 million related to the Saudi Arabia customs assessments
Note: Sum of product categories or Regions might not foot to Total PMI due to roundings. “-“ indicates amounts between -$0.5 million and +$0.5 million
Currency
Net
Revenues
excluding
Currency
Acquisitions
Net
Revenues
excluding
Currency &
Acquisitions
Years Ended
December 31,
Net
Revenues 	Total 	Excluding
Currency
Excluding
Currency &
Acquisitions
2021 	Reduced-Risk Products 	2020 	% Change
$ 4,064 	$ 193 	$ 3,871 	$ 8 	$ 3,863 	European Union 	$ 2,649 	53.4% 	46.1% 	45.8%
1,304 	(28) 	1,332 	- 	1,332 	Eastern Europe 	1,128 	15.6% 	18.1% 	18.1%
145 	1 	144 	- 	144 	Middle East & Africa 	57 	+100% 	+100% 	+100%
11 	- 	11 	- 	11 	South & Southeast Asia 	1 	+100% 	+100% 	+100%
3,539 	7 	3,532 	- 	3,532 	East Asia & Australia 	2,961 	19.5% 	19.3% 	19.3%
53 	1 	52 	- 	52 	Americas 	31 	68.0% 	64.0% 	64.0%
$ 9,115 	$ 174 	$ 8,940 	$ 8 	$ 8,932 	Total RRPs 	$ 6,827 	33.5% 	30.9% 	30.8%
2021 	Other 	2020 	% Change
$ 101 	$ - 	$ 101 	$ 101 	$ - 	Other 	$ - 	- 	- 	-
2021 	PMI 	2020 	% Change
$ 12,275 	$ 618 	$ 11,657 	$ 8 	$ 11,649 	European Union 	$ 10,702 	14.7% 	8.9% 	8.8%
3,544 	(32) 	3,576 	- 	3,576 	Eastern Europe 	3,378 	4.9% 	5.9% 	5.9%
3,293 (a)	
(115) 	3,408 	- 	3,408 	Middle East & Africa 	3,088 	6.6% 	10.4% 	10.4%
4,396 	99 	4,297 	- 	4,297 	South & Southeast Asia 	4,396 	- 	(2.3)% 	(2.3)%
5,953 	62 	5,891 	- 	5,891 	East Asia & Australia 	5,429 	9.7% 	8.5% 	8.5%
1,843 	46 	1,797 	- 	1,797 	Americas 	1,701 	8.3% 	5.6% 	5.6%
101 	- 	101 	101 	- 	Other 	- 	- 	- 	-
$ 31,405 	$ 678 	$ 30,727 	$ 109 	$ 30,618 	Total PMI 	$ 28,694 	9.4% 	7.1% 	6.7%
Net
Revenues

-- 25 of 28 --

51
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Net Revenues to Adjusted Net Revenues, excluding Currency and Acquisitions
($ in millions) / (Unaudited)
(a) Represents the Saudi Arabia customs assessments
Net
Revenues
Adjusted
Net
Revenues
Currency
Adjusted
Net
Revenues
excluding
Currency
Acqui-
sitions
Adjusted
Net
Revenues
excluding
Currency
& Acqui-
sitions
Net
Revenues
Adjusted
Net
Revenues
Total 	Excluding
Currency
Excluding
Currency
& Acqui-
sitions
2021 	2020
$ 12,275 	$ - 	$ 12,275 	$ 618 	$ 11,657 	$ 8 	$ 11,649 	European Union 	$ 10,702 	$ - 	$ 10,702 	14.7% 	8.9% 	8.8%
3,544 	- 	3,544 	(32) 	3,576 	- 	3,576 	Eastern Europe 	3,378 	- 	3,378 	4.9% 	5.9% 	5.9%
3,293 	(246) (a)	
3,539 	(115) 	3,654 	- 	3,654 	Middle East & Africa 	3,088 	- 	3,088 	14.6% 	18.3% 	18.3%
4,396 	- 	4,396 	99 	4,297 	- 	4,297 	South & Southeast Asia 	4,396 	- 	4,396 	- 	(2.3)% 	(2.3)%
5,953 	- 	5,953 	62 	5,891 	- 	5,891 	East Asia & Australia 	5,429 	- 	5,429 	9.7% 	8.5% 	8.5%
1,843 	- 	1,843 	46 	1,797 	- 	1,797 	Americas 	1,701 	- 	1,701 	8.3% 	5.6% 	5.6%
101 	- 	101 	- 	101 	101 	- 	Other 	- 	- 	- 	- 	- 	-
$ 31,405 $ (246) 	$ 31,651 	$ 678 	$ 30,973 	$ 109 	$ 30,864 	Total PMI 	$ 28,694 	$ - 	$ 28,694 	10.3% 	7.9% 	7.6%
Years Ended
December 31, 	% Change
Special
Items
Special
Items
52
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Operating Income to Adjusted Operating Income, excluding Currency and Acquisitions
($ in millions) / (Unaudited)
(a) Represents asset impairment and exit costs
(b) Includes the Saudi Arabia customs assessments ($246 million) and asset impairment and exit costs ($17 million)
(c) Represents asset acquisition cost related to OtiTopic Inc. in August 2021
(d) Includes the Brazil indirect tax credit $119 million and asset impairment and exit costs ($9 million)
Operating
Income
Adjusted
Operating
Income
Currency
Adjusted
Operating
Income
excluding
Currency
Acqui-
sitions
Adjusted
Operating
Income
excluding
Currency
& Acqui-
sitions
Operating
Income
Adjusted
Operating
Income
Total 	Excluding
Currency
Excluding
Currency
& Acqui-
sitions
2021 	2020
$ 6,119 	$ (68) (a)	
$ 6,187 	$ 384 	$ 5,803 	$ 2 	$ 5,801 	European Union 	$ 5,098 	$ (57) (a)	
$ 5,155 	20.0% 	12.6% 	12.5%
1,213 	(14) (a)	
1,227 	7 	1,220 	- 	1,220 	Eastern Europe 	871 	(15) (a)	
886 	38.5% 	37.7% 	37.7%
1,146 	(263) (b)	
1,409 	(124) 	1,533 	- 	1,533 	Middle East & Africa 	1,026 	(19) (a)	
1,045 	34.8% 	46.7% 	46.7%
1,506 	(21) (a)	
1,527 	36 	1,491 	- 	1,491 	South & Southeast Asia 	1,709 	(23) (a)	
1,732 	(11.8)% 	(13.9)% 	(13.9)%
2,556 	(88) (a)	
2,644 	(53) 	2,697 	- 	2,697 	East Asia & Australia 	2,400 	(26) (a)	
2,426 	9.0% 	11.2% 	11.2%
487 	(8) (a)	
495 	18 	477 	- 	477 	Americas 	564 	110 (d)	
454 	9.0% 	5.1% 	5.1%
(52) 	(51) (c)	
(1) 	- 	(1) 	(1) 	- 	Other 	- 	- 	- 	- 	- 	-
$ 12,975 	$ (513) 	$ 13,488 	$ 268 	$ 13,220 	$ 1 	$ 13,219 	Total PMI 	$ 11,668 	$ (30) 	$ 11,698 	15.3% 	13.0% 	13.0%
Asset
Impairment
& Exit Costs
and Others
% Change
	Years Ended
December 31,
Asset
Impairment
& Exit Costs

-- 26 of 28 --

53
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Adjusted Operating Income Margin, excluding Currency and Acquisitions
($ in millions) / (Unaudited)
(a) For the calculation of Adjusted Operating Income and Adjusted Operating Income excluding currency and acquisitions refer to slide 52
(b) For the calculation of Adjusted Net Revenues excluding currency and acquisitions refer to slide 51
Adjusted
Operating
Income
(a)
Adjusted
Net
Revenues
(b)
Adjusted
Operating
Income
Margin
Adjusted
Operating
Income
excluding
Currency
(a)
Adjusted
Net
Revenues
excluding
Currency
(b)
Adjusted
Operating
Income
Margin
excluding
Currency
Adjusted
Operating
Income
excluding
Currency &
Acqui-
sitions (a)
Adjusted
Net
Revenues
excluding
Currency &
Acqui-
sitions (b)
Adjusted
Operating
Income
Margin
excluding
Currency &
Acqui-
sitions
Adjusted
Operating
Income
(a)
Adjusted
Net
Revenues
(b)
Adjusted
Operating
Income
Margin
Adjusted
Operating
Income
Margin
Adjusted
Operating
Income
Margin
excluding
Currency
Adjusted
Operating
Income
Margin
excluding
Currency &
Acqui-
sitions
2021 	2020 	% Points Change
$ 6,187 $ 12,275 	50.4% 	$ 5,803 $ 11,657 	49.8% 	$ 5,801 $ 11,649 	49.8% 	European Union 	$ 5,155 $ 10,702 	48.2% 	2.2 	1.6 	1.6
1,227 	3,544 	34.6% 	1,220 	3,576 	34.1% 	1,220 	3,576 	34.1% 	Eastern Europe 	886 	3,378 	26.2% 	8.4 	7.9 	7.9
1,409 	3,539 	39.8% 	1,533 	3,654 	42.0% 	1,533 	3,654 	42.0% 	Middle East & Africa 	1,045 	3,088 	33.8% 	6.0 	8.2 	8.2
1,527 	4,396 	34.7% 	1,491 	4,297 	34.7% 	1,491 	4,297 	34.7% South & Southeast Asia 	1,732 	4,396 	39.4% 	(4.7) 	(4.7) 	(4.7)
2,644 	5,953 	44.4% 	2,697 	5,891 	45.8% 	2,697 	5,891 	45.8% 	East Asia & Australia 	2,426 	5,429 	44.7% 	(0.3) 	1.1 	1.1
495 	1,843 	26.9% 	477 	1,797 	26.5% 	477 	1,797 	26.5% 	Americas 	454 	1,701 	26.7% 	0.2 	(0.2) 	(0.2)
(1) 	101 	(1.0)% 	(1) 	101 	(1.0)% 	- 	- 	- 	Other 	- 	- 	- 	- 	- 	-
$ 13,488 $ 31,651 	42.6% $ 13,220 $ 30,973 	42.7% $ 13,219 $ 30,864 	42.8% 	Total PMI 	$ 11,698 $ 28,694 	40.8% 	1.8 	1.9 	2.0
Years Ended
December 31,
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Net Revenues by Product Category
($ in millions) / (Unaudited)
(a) Includes a reduction in net revenues of $246 million related to the Saudi Arabia customs assessments
Note: Sum of Regions might not foot to Total PMI due to roundings. "-" indicates amounts between -$0.5 million and +$0.5 million 	54
Years Ended
December 31,
Reduced-Risk Products 	2021 	2020 	2019 	2018 	2017 	2016 	2015
European Union 	$ 4,064 	$ 2,649 	$ 1,724 	$ 865 	$ 269 	$ 57 	$ 29
Eastern Europe 	1,304 	1,128 	844 	324 	55 	6 	-
Middle East & Africa 	145 	57 	321 	382 	94 	4 	-
South & Southeast Asia 	11 	1 	- 	- 	- 	- 	-
East Asia & Australia 	3,539 	2,961 	2,671 	2,506 	3,218 	666 	35
Americas 	53 	31 	27 	19 	4 	1 	-
Total RRPs 	$ 9,115 	$ 6,827 	$ 5,587 	$ 4,096 	$ 3,640 	$ 733 	$ 64
Other 	2021 	2020 	2019 	2018 	2017 	2016 	2015
Other 	$ 101 	- 	- 	- 	- 	- 	-
PMI 	2021 	2020 	2019 	2018 	2017 	2016 	2015
European Union 	$ 12,275 	$ 10,702 	$ 9,817 	$ 9,298 	$ 8,318 	$ 8,162 	$ 8,068
Eastern Europe 	3,544 	3,378 	3,282 	2,921 	2,711 	2,484 	2,735
Middle East & Africa 	3,293 (a) 	3,088 	4,042 	4,114 	3,988 	4,516 	4,629
South & Southeast Asia 	4,396 	4,396 	5,094 	4,656 	4,417 	4,396 	4,288
East Asia & Australia 	5,953 	5,429 	5,364 	5,580 	6,373 	4,285 	3,915
Americas 	1,843 	1,701 	2,206 	3,056 	2,941 	2,842 	3,159
Other 	101 	- 	- 	- 	- 	- 	-
Total PMI 	$ 31,405 	$ 28,694 	$ 29,805 	$ 29,625 	$ 28,748 	$ 26,685 	$ 26,794
Net
Revenues

-- 27 of 28 --

Delivering a Smoke-Free Future
2021 Fourth-Quarter and
Full-Year Results
February 10, 2022

-- 28 of 28 --